glp-1 obesity drug news today oct 23 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Pharma Giants Bet on Next-Generation

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

INNOVATIVE 3-STEP SYNBIOTIC FORMULA - Unique combination of postbiotics (Tribiome), prebiotics (Sukre), and probiotics (15 Billion CFU) works synergistically to optimize gut health, enhance metabolic balance, and support the gut-brain axis

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x higher Noom stands behind its program with a Taper-Off Guarantee offering a pathway off supposedly forever medications. Solves the biggest real-world challenges with GLP-1s poor persistence and lean muscle loss by pairing the medication with Noom GLP-1 Companion with Muscle DefenseTM

Did you know that individuals using semaglutide experience average weight reductions ranging from 9.6% to 17.4% of their initial body weight

These benefits span multiple biological systems including the nervous, musculoskeletal and respiratory systems

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes